1. Introduction

The legality of artificial organ resale depends primarily on what is being resold, how it was manufactured, whether it is a medical device or a biological product, and whether the transaction complies with applicable medical-device, product-safety, intellectual-property, and commercial laws.

The central legal distinction is between reselling an artificial organ as a manufactured medical device and selling a human organ or biological material. These are not legally equivalent transactions.

An artificial organ may include a mechanical heart valve, an artificial heart, a dialysis-related implant, a prosthetic organ, or a bioengineered organ incorporating living cells. The legal framework can differ substantially between these products.

This explanation focuses principally on Indian law, with comparative legal principles and relevant judicial decisions.

2. Meaning and scope of artificial organ resale

An artificial organ is a manufactured or engineered device intended to replace, support, or replicate some function of a natural organ. Examples include:

Mechanical heart and circulatory devices

Devices that support or replace cardiac function. Resale raises questions about device regulation, traceability, servicing, and patient safety.

Prosthetic and implantable devices

Manufactured implants may be transferable through lawful commercial channels, subject to applicable licensing, quality, and distribution requirements.

Bioengineered or hybrid organs

Products incorporating living cells, tissues, or biological materials may trigger additional biosafety, biological-product, research, and clinical-use requirements.

The resale question may arise when a hospital sells unused inventory, a distributor transfers stock, a patient seeks to transfer an unused device, a company resells a refurbished implant, or a manufacturer attempts to commercialize a bioengineered organ.

Each situation requires a separate legal analysis.

3. Indian statutory framework

A. Transplantation of Human Organs and Tissues Act, 1994

The principal legislation governing the commercial sale of human organs in India is the Transplantation of Human Organs and Tissues Act, 1994 (THOTA), as amended.

Its stated purpose includes regulating the removal, storage, and transplantation of human organs and tissues and preventing commercial dealings in them.

Ministry of Health and Family Welfare

+1

Section 19: Commercial dealings in human organs

Section 19 prohibits specified activities involving payment for supplying human organs. Its scope includes:

Making or receiving payment for the supply of a human organ.

Finding a person willing to supply an organ for payment.

Offering an organ for payment.

Initiating or negotiating a paid organ-supply arrangement.

Participating in the management of an organization involved in such arrangements.

Publishing advertisements offering or soliciting organs for payment.

The section also provides for criminal penalties. The current statutory text and applicable amendments must be consulted to determine the precise punishment in a particular case.

India Code

+1

Does Section 19 prohibit resale of an artificial organ?

Not merely because the product is called an artificial organ. A purely manufactured device is not automatically a human organ within the meaning of THOTA. The decisive question is the product's legal and biological character.

For example:

Reselling a manufactured mechanical heart through a lawful medical-device supply chain is not, simply by that fact, the sale of a human heart.

Selling a donated human heart for profit is prohibited.

Selling a hybrid product that incorporates human tissue requires closer examination of its composition and the applicable statutory provisions.

Section 19A separately addresses illegal dealings in human tissues. Consequently, a seller cannot avoid the law merely by describing a transaction as the resale of a product if the underlying transaction involves prohibited human-organ or tissue dealings.

IndiaCode

+1

B. Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017

Manufactured artificial organs intended for medical use may fall within the definition of a medical device under Indian law. The Central Drugs Standard Control Organisation (CDSCO) identifies the Drugs and Cosmetics Act, 1940, and the Medical Devices Rules, 2017, as the principal regulatory framework for medical devices.

CDSCO

+1

For a proposed resale, the relevant issues include:

Regulatory status: Whether the device is authorized for the intended use and complies with applicable manufacturing or import requirements.

Seller eligibility: Whether the seller must hold a licence or satisfy registration requirements for sale, stocking, or distribution.

Storage and transport: Whether required conditions have been maintained, especially for sterile or implantable products.

Traceability: Whether batch numbers, serial numbers, invoices, and relevant product records are available.

Product safety: Whether the product has been recalled, damaged, contaminated, modified, or rendered unsuitable for implantation.

Rule 87 addresses the sale of medical devices, while Rule 88 provides a specific mechanism for supplying invasive medical devices to hospitals against delivery challans, subject to prescribed conditions. Rule 89 deals with recalls where a device may be unsafe.

IndiaCode

+1

These provisions regulate medical-device commerce, but they do not create a general right to resell every previously implanted or used artificial organ.

C. Consumer Protection Act, 2019

The Consumer Protection Act, 2019, may become relevant where a patient purchases a defective or misrepresented artificial organ or where a commercial seller fails to meet applicable consumer-protection obligations.

Potential disputes include:

Selling a counterfeit or falsely described device.

Concealing that a device has been used or refurbished.

Misrepresenting the remaining useful life of an implant.

Supplying a defective product that causes injury.

Failing to disclose material safety limitations.

The applicable remedy depends on the facts, the identity of the claimant, the nature of the transaction, and the relevant statutory requirements.

D. Contract and intellectual-property law

A commercial resale may also involve the Sale of Goods Act, 1930, contract law, patent law, and trademark law.

For example, an authorized distributor may be able to transfer lawful ownership of unused inventory, while a dispute over unauthorized modification, counterfeit branding, or contractual resale restrictions may require a different analysis.

A purchaser's ownership of a physical device should not be confused with ownership of the manufacturer's intellectual property or authorization to alter the device.

4. Case laws and judicial principles

A significant qualification is necessary: Indian reported judgments specifically deciding the resale of a manufactured artificial organ are limited. The following decisions establish relevant legal principles, rather than a special rule authorizing artificial-organ resale.

Case 1: Common Cause v. Union of India (2018)

Supreme Court of India · (2018) 5 SCC 1

Legal issue: Autonomy, dignity, and medical decision-making at the end of life.

The Supreme Court recognized the constitutional significance of dignity and autonomy in medical decisions, including decisions concerning withdrawal of life-sustaining treatment in specified circumstances.

Relevance to artificial organs: The decision helps explain why artificial-organ treatment cannot be analyzed solely as a commercial transaction. Patient autonomy, informed consent, dignity, and clinical judgment remain central.

Limitation: This case did not decide whether artificial organs may be resold. It is relevant to the surrounding constitutional and medical-ethics framework.

Case 2: Samira Kohli v. Dr. Prabha Manchanda (2008)

Supreme Court of India · (2008) 2 SCC 1

Legal issue: Informed consent in medical treatment.

The Supreme Court explained the importance of obtaining valid consent for medical procedures and distinguished consent to one procedure from consent to a materially different procedure.

Relevance to artificial organs: If a previously owned, refurbished, or modified implant is proposed for use in a patient, consent alone cannot make an otherwise unlawful or unsafe product lawful. Nevertheless, accurate disclosure of the device's nature, risks, and proposed use is important to lawful treatment.

Principle: Commercial ownership and medical authorization are separate questions.

Case 3: Indian Medical Association v. V.P. Shantha (1995)

Supreme Court of India · (1995) 6 SCC 651

Legal issue: Application of consumer-protection law to medical services.

The Court examined when medical services fall within the consumer-protection framework, including the significance of consideration and the treatment arrangements involved.

Relevance to artificial organs: Disputes may arise where a hospital or seller supplies an artificial organ as part of a paid medical service. Depending on the facts, consumer remedies may be relevant to defective products, misleading representations, or deficiencies in covered services.

Limitation: The judgment does not independently determine the regulatory status or resale eligibility of an artificial organ.

Case 4: Amar Singh Bhatia v. Sir Ganga Ram Hospital (Delhi High Court, 4 January 2024)

W.P. (C) 3590/2020

Legal issue: Regulation of human-organ transplantation and the prevention of commercial exploitation.

The Delhi High Court discussed the purpose of THOTA and emphasized the distinction between permitting lawful transplantation and prohibiting commercial dealings in human organs. The decision also addressed the responsibilities of authorization committees in examining whether a proposed donation is genuine.

Indian Kanoon

+1

Relevance: This is a useful authority for understanding the boundary between lawful medical activity and prohibited organ trafficking.

Application to artificial organs: The case does not directly govern the resale of a wholly manufactured device. Its relevance arises where a supposedly artificial product is actually a vehicle for prohibited transactions involving human organs or tissues.

Case 5: Kuldeep Singh v. State of Tamil Nadu (2005)

Supreme Court of India · Writ Petition (Civil) No. 156 of 2005, decided 31 March 2005

Legal issue: The competent authority for approving transplantation involving donors who are not near relatives.

The Supreme Court examined the authorization process and the need to ensure that transplantation is not motivated by prohibited commercial consideration. It stressed the statutory objective of preventing commercial dealings in human organs.

NearLaw

+1

Relevance: The case illustrates why the legal characterization of the transaction matters more than the terminology used by the parties. However, it concerns human-organ transplantation, not ordinary resale of manufactured medical devices.

Case 6: Dr. Jyoti Bansal v. State of Rajasthan (2024)

Rajasthan High Court · S.B. Criminal Miscellaneous Petition No. 2715/2024, decided 30 May 2024

Legal issue: Allegations of commercial dealings in human organs during an investigation into an alleged kidney-transplant racket.

The court declined to quash the proceedings at the investigation stage in light of the allegations concerning paid donors, intermediaries, and financial transactions. The case demonstrates the potential criminal consequences of alleged organ-trafficking arrangements.

IndiaCode

Relevance: A company cannot necessarily avoid scrutiny by using commercial terminology if the actual transaction involves the prohibited supply of human organs for payment. The case does not establish that the resale of a manufactured artificial organ is itself a crime.

5. Legality of different resale transactions

The following table summarizes the principal distinctions under Indian law.

The distinction between new, unused stock and a previously implanted device is particularly important. Medical Devices Rules, 2017, contain provisions governing sales and recalls, but those provisions should not be interpreted as a blanket authorization for the commercial reuse of implanted artificial organs.

IndiaCode

+1

6. International legal principles

The World Health Organization's Guiding Principles on Human Cell, Tissue and Organ Transplantation distinguish voluntary donation from prohibited commercial purchase and sale. They also recognize that reasonable, verifiable expenses associated with donation and the recovery, processing, preservation, and supply of biological materials may be reimbursed without necessarily constituting prohibited payment for the organ itself.

TTS

This distinction is important for hybrid artificial organs. A commercial price for a manufactured medical device is not automatically equivalent to payment for a human organ. Conversely, a product's manufactured components do not make a transaction lawful if it involves prohibited commercial dealings in human biological material.

International principles provide useful context, but the enforceable rules depend on the applicable domestic legislation.

7. Practical legal compliance checklist

Before reselling an artificial organ in India, a business or institution should establish the following:

Compliance review

0 of 7

Identify whether the product is wholly synthetic, biological, or hybrid.

Verify the device's regulatory classification and applicable authorization.

Confirm the seller's licence or registration requirements.

Establish that the product is unused or that any proposed reuse is legally and medically permissible.

Check sterility, storage, maintenance, traceability, and recall status.

Review warranties, contractual restrictions, intellectual-property rights, and disclosure obligations.

Obtain specialist regulatory advice where human cells or tissues are incorporated.

For official regulatory guidance, consult the Central Drugs Standard Control Organisation (CDSCO) and the applicable Medical Devices Rules, 2017.

CDSCO

+1

8. Conclusion

Under Indian law, resale of an artificial organ is not automatically prohibited merely because the product replaces a natural organ. Its legality depends on the product's nature, regulatory classification, condition, intended use, and the seller's compliance with applicable requirements.

THOTA prohibits commercial dealings in human organs and separately regulates illegal dealings in human tissues. The Medical Devices Rules, 2017, provide a framework for the sale and distribution of regulated medical devices, but do not establish a general permission to resell previously implanted artificial organs.

The judicial decisions discussed above help clarify consent, medical autonomy, transplantation authorization, and the prohibition on commercial organ trafficking. None should be misrepresented as a direct ruling that all artificial-organ resale is lawful or unlawful.

Legal note: This is a general research explanation, not an opinion on a particular transaction. The governing rules may depend on whether the proposed product is a mechanical implant, a refurbished device, a bioengineered organ, or a product containing human tissue.